Clinical Trial

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

Name: Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC — clinical trial record (NCT07225374)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated November 6, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

A Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma

Trial Details

NCT Number	NCT07225374
Lead Sponsor	Samsung Medical Center
Conditions	Upper Tract Urothelial Carcinoma
Enrollment	48 participants
Start Date	2025-09-16
Primary Completion	2026-07-01 (estimated)
Study Completion	2029-07-02 (estimated)
Updated on ClinicalTrials.gov	2025-11-06